Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash & Current Investments (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Cash & Current Investments data on record, last reported at $285.9 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 138.3% year-over-year to $285.9 million; the TTM value through Sep 2025 reached $285.9 million, up 138.3%, while the annual FY2024 figure was $95.6 million, 69.23% down from the prior year.
  • Cash & Current Investments reached $285.9 million in Q3 2025 per COLL's latest filing, up from $137.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $325.5 million in Q2 2023 and bottomed at $95.6 million in Q4 2024.
  • Average Cash & Current Investments over 5 years is $203.0 million, with a median of $186.4 million recorded in 2021.
  • Peak YoY movement for Cash & Current Investments: soared 165.21% in 2023, then plummeted 69.23% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $186.4 million in 2021, then fell by 6.83% to $173.7 million in 2022, then soared by 78.8% to $310.5 million in 2023, then tumbled by 69.23% to $95.6 million in 2024, then skyrocketed by 199.13% to $285.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $285.9 million in Q3 2025, $137.2 million in Q2 2025, and $116.0 million in Q1 2025.